Search For "pfizer"
Updated : 1 day, 1 hour ago IST
Washington [US], September 18 (ANI): The US Food and Drug Administration advisory (FDA) committee on Friday (local time) voted unanimously to authorize Pfizer booster shots for use in people aged 65-plus and high-risk patients following a prior failed vote to approve third shots for all p
Updated : 21 hours, 13 min ago IST
New Delhi [India], September 18 (ANI): World Health Organisation's (WHO) approval for the emergency use authorisation (EUA) to COVID-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is likely to be delayed till October 5.
Updated : 5 days, 20 hours ago IST
Islamabad [Pakistan], September 13 (ANI): Pakistan reported 2,988 fresh cases of COVID-19 after 53,158 tests were conducted across the country in the last 24 hours, according to Pakistan's National Command and Operation Centre (NCOC) data.
Updated : 2 weeks, 1 day ago IST
Canberra [Australia], September 3 (ANI/Xinhua): The Australian government has secured another 4 million doses of coronavirus vaccine in a deal with Britain as the country continued to battle the third wave of COVID-19 infections.
Updated : 2 weeks, 4 days ago IST
Washington [US], August 31 (ANI): A new study has shown that two months after the second Pfizer/Moderna vaccination, antibody response decreases 20 per cent in adults with prior cases of COVID-19. The study also tested how well current vaccines resist emerging variants.
Updated : 2 weeks, 5 days ago IST
Washington [US], August 31 (ANI/Sputnik): A key advisory panel of the US Centers for Disease Control and Prevention (CDC) said on Monday that it has unanimously endorsed the full approval of the Pfizer-BioNTech's COVID-19 vaccine for Americans aged 16 and older.
Updated : 3 weeks ago IST
London [UK], August 28 (ANI): A new study has revealed that the side effects of the Pfizer-BioNTech jab against COVID-19 in 12-15-year-olds at high risk of complications from the infection are likely to be mild to moderate and clear up quickly because of certain coexisting conditions.
Updated : 3 weeks, 1 day ago IST
London [UK], August 27 (ANI): A new study has revealed that the side effects of the Pfizer-BioNTech jab against COVID-19 in 12-15-year-olds at high risk of complications from the infection are likely to be mild to moderate and clear up quickly because of certain coexisting conditions.
Updated : 3 weeks, 5 days ago IST
Washington [US] August 23 (ANI): The US Food and Drug Administration (FDA) on Monday gave full approval to Pfizer's COVID-19 vaccine.
Updated : 1 month ago IST
Washington [US], August 19 (ANI): Booster shots of the Pfizer and Moderna COVID-19 vaccines are set to become available for all adults in America beginning next month, the country's top health officials announced on Wednesday.
New York [US], August 17 (ANI): Pfizer and BioNTech announced that they have submitted Phase 1 data to the United States Food and Drug Administration (FDA) to support the evaluation of a third, or booster dose of the companies' COVID-19 vaccine for future licensure.
Washington [US] August 13 (ANI/FENA): US drug regulators say transplant recipients and others with severely weakened immune systems may receive an extra dose of Pfizer or Moderna to better protect them as the delta variant of the coronavirus continues to spread.